Resource Center

Dec 21, 2021

A supramolecular thermosensitive gel of ketoconazole for ocular applications: In silico, in vitro, and ex vivo studies

Abstract

The incidence of corneal fungal infections continues to be a growing concern worldwide. Ocular delivery of anti-fungal drugs is challenging due to the anatomical and physiological barriers of the eye. The ocular bioavailability of ketoconazole (KTZ), a widely prescribed antifungal agent, is hampered by its limited aqueous solubility and permeation. In the study, the physicochemical properties of KTZ were improved by complexation with sulfobutylether-β-cyclodextrin (SBE-β-CD). KTZ-SBE-β-CD complex was studied in silico with docking and dynamics simulations, followed by wet-lab experiments. The optimized KTZ-SBE-β-CD complex was loaded into a thermosensitive in situ gel to increase corneal bioavailability. The supramolecular complex increased the solubility of KTZ by 5-folds and exhibited a 10-fold increment in drug release compared to the pure KTZ. Owing to the diffusion, the in situ gel exhibited a more sustained drug release profile. The ex vivo corneal permeation studies showed higher permeation from KTZ-SBE-β-CD in situ gel (flux of ∼19.11 µg/cm2/h) than KTZ in situ gel (flux of ∼1.17 µg/cm2/h). The cytotoxicity assays and the hen’s egg chorioallantoic membrane assay (HET-CAM) confirmed the formulations’ safety and non-irritancy. In silico guided design of KTZ-SBE-β-CD inclusion complexes successfully modified the physicochemical properties of KTZ. In addition, the loading of the KTZ-SBE-β-CD complex into an in situ gel significantly increased the precorneal retention and permeation of KTZ, indicating that the developed formulation is a viable modality to treat fungal keratitis.

 

By Pinal Chaudhari, Ranjitha Naik, Lakshmi Sruthi Mallela, Sanhita Roy, Sumit Birangal, Vivek Ghate, Sarojini Balladka Kunhanna, Shaila A. Lewis

Contact Us About This Journal Article